With reference to email ref no. L/SURV/ONL/PV/AA/ 2025-2026 / 689 dated 20.11.2025 with regard to increase in volume of securities of Venus Remedies, Venus Remedies has informed that the company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 from time to time and has not withheld any material information that in its opinion would have a bearing on the price / volume behaviour in the company's script. The said significant increase in the volume of security is likely because of positive quarterly results and is purely market driven.
The above information is a part of company’s filings submitted to BSE.
